Contemporary diagnosis of bladder cancer

Bibliography

• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108
   PubMed Web of Science ®Google Scholar
• Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005;66(suppl 6A):4-34
   PubMed Web of Science ®Google Scholar
• Tsukamoto T, Kitamura H, Takahashi A, Masumori N. Treatment of invasive bladder cancer: Lessons from the past and perspective for the future. Jpn J Clin Oncol 2004;34:295-306
   PubMed Web of Science ®Google Scholar
• Carmack AJK, Soloway MS. The diagnosis and staging of bladder cancer: from RBCs to TURs. Urology 2006;67(suppl 3A):3-10
   PubMed Web of Science ®Google Scholar
• Messing EM, Vaillancourt A. Hematuria screening for bladder cancer. J Occup Med 1990;32:838-45
   PubMedGoogle Scholar
• Jewett HJ. Proceedings: cancer of the bladder. Diagnosis and staging. Cancer 1973;32:1072-4
   PubMed Web of Science ®Google Scholar
• Goessl C, Knispel HH, Miller K, Klan R. Is routine excretory urography necessary at first diagnosis of bladder cancer? J Urol 1997;157:480-1
   PubMed Web of Science ®Google Scholar
• Herranz-Amo F, Diez-Cordero JM, Verdu-Tartajo F, et al. Need for intravenous urography in patients with primary transitional carcinoma of the bladder. Eur Urol 1999;36:221-4
   PubMed Web of Science ®Google Scholar
• Ozden E, Turgut AT, Turkolmez K, et al. Effect of bladder carcinoma location on detection rates by ultrasonography and computed tomography. Urology 2007;69:889-92
   PubMed Web of Science ®Google Scholar
• Mitterberger M, Pingerra GM, Neuwirt H, et al. Three-dimensional ultrasonography of the urinary bladder: preliminary experience of assessment in patients with haematuria. BJU Int 2007;99:111-6
   PubMed Web of Science ®Google Scholar
• Turney BW, Willatt JM, Nixon D, et al. Computed tomography urography for diagnosing bladder cancer. BJU Int 2006;98:345-8
   PubMed Web of Science ®Google Scholar
• Anderson EM, Murphy R, Rennie ATM, Cowan NC. Multidetector computed tomography urography (MDCTU) for diagnosing urothelial malignancy. Clin Radiol 2007;62:324-32
   PubMed Web of Science ®Google Scholar
• Beyersdorff D, Zhang J, Schoeder H, et al. Bladder cancer: can imaging change patient management? Curr Opin Urol 2008;18:98-104
   PubMed Web of Science ®Google Scholar
• Setty BN, Holalkere NS, Sahani DV, et al. State-of-the-art cross-sectional imaging in bladder cancer. Curr Probl Diagn Radiol 2007;36:83-96
   PubMedGoogle Scholar
• Saksena MA, Dahl DM, Harisinghani MG. New imaging modalities in bladder cancer. World J Urol 2006;24:473-80
   PubMed Web of Science ®Google Scholar
• Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004;34:274-92
   PubMed Web of Science ®Google Scholar
• Powles T, Murray I, Brock C, et al. Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol 2007;51:1511-21
   PubMed Web of Science ®Google Scholar
• Fanti S, Nanni C, Ambrosini V, et al. PET in genitourinary tract cancers. Q J Nucl Med Mol Imaging 2007;51:260-71
   PubMed Web of Science ®Google Scholar
• Glatz K, Willi N, Glatz D, et al. An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system. Am J Clin Pathol 2006;126:294-301
   PubMed Web of Science ®Google Scholar
• Gregoire M, Fradet Y, Meyer F, et al. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup of bladder tumors. J Urol 1997;157:1660-4
   PubMed Web of Science ®Google Scholar
• Badalament RA, Hermansen DK, Kimmel M, et al. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer 1987;60:1423-7
   PubMed Web of Science ®Google Scholar
• Fradet Y, Tardif M, Bourget L, et al. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group. Cancer Res 1990;50:432-7
   PubMed Web of Science ®Google Scholar
• Carter HB, Amberson JB, Bander NH, et al. Newer diagnostic techniques for bladder cancer. Urol Clin North Am 1987;14:763-9
   PubMed Web of Science ®Google Scholar
• Parry WL, Hemstreet GP 3d. Cancer detection by quantitative fluorescence image analysis. J Urol 1988;39:270-4
   Google Scholar
• Tinzl M, Marberger M. Urinary markers for detecting bladder cancer. EAU Update Series 2003;1:64-70
   Google Scholar
• Lokeshwar VB, Habuchi T, Grossman HB, et al. Bladder tumor markers beyond cytology: International consensus panel on bladder tumor markers. Urology 2005;66(Suppl 6A):35-63
   PubMed Web of Science ®Google Scholar
• Liou LS. Urothelial cancer biomarkers for detection and surveillance. Urology 2006;67(Suppl 3A):25-34
   PubMed Web of Science ®Google Scholar
• Tiguert R, Fradet Y. New diagnostic and prognostic tools in bladder cancer. Curr Opin Urol 2002;12:239-43
   PubMed Web of Science ®Google Scholar
• Alvarez A, Lokeshwar VB. Bladder cancer biomarkers: current developments and future implementation. Curr Opin Urol 2007;17:341-6
   PubMed Web of Science ®Google Scholar
• Jones JS. DNA-based molecular cytology for bladder cancer surveillance. Urology 2006;67(suppl 3A):35-47
   PubMedGoogle Scholar
• Van Rhijn BWG, Van Der Poel HG, Van Der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 2005;47:736-48
   PubMed Web of Science ®Google Scholar
• Nielsen ME, Schaeffer EM, Veltri RW, et al. Urinary markers in the detection of bladder cancer: what's new? Curr Opin Urol 2006;16:350-6
   PubMed Web of Science ®Google Scholar
• Konety BR. Molecular markers in bladder cancer: a critical appraisal. Urol Oncol 2006;24:326-37
   PubMed Web of Science ®Google Scholar
• Vrooman OPJ, Witjs JA. Urinary markers in bladder cancer. Eur Urol 2008;53(5):909-16
   PubMed Web of Science ®Google Scholar
• Moonen PMJ, Merkx GFM, Peelen P, et al. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer. Eur Urol 2007;51:1275-80
   PubMed Web of Science ®Google Scholar
• May M, Hakenberg OW, Gunia S, et al. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice. Urology 2007;70:449-53
   PubMed Web of Science ®Google Scholar
• Dalbagni G, Presti J, Reuter V, et al. Genetic alterations in bladder cancer. Lancet 1993;342:469-71
   PubMed Web of Science ®Google Scholar
• Hoque MO, Lee J, Begum S, et al. High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array. Cancer Res 2003;63:5723-6
   PubMed Web of Science ®Google Scholar
• Young MJ, Soloway MS. Office evaluation and management of bladder neoplasms. Urol Clin North Am 1998;25:603-11
   PubMed Web of Science ®Google Scholar
• Pashos CL, Botteman MF, Laskin BL, et al. Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract 2002;10:311-22
   PubMedGoogle Scholar
• Cina SJ, Epstein JI, Endrizzi JM, et al. Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder. Hum Pathol 2001;32:630-7
   PubMed Web of Science ®Google Scholar
• Herr HW. Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder? BJU Int 2001;88:683-5
   PubMed Web of Science ®Google Scholar
• Herr HW, Donat SM, Dalbagni G. Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. J Urol 2002;168:978-80
   PubMed Web of Science ®Google Scholar
• Mitropoulos D, Kiroudi-Voulgari A, Nikolopoulos P, et al. Accuracy of cystoscopy in predicting histologic features of bladder lesions. J Endourol 2005;19:861-4
   PubMed Web of Science ®Google Scholar
• De Leon Morales E, Arango Toro O, Lorente Garin JA, et al. Cystoscopic impression versus histologic diagnosis in bladder tumors. Do they coincide? Actas Urol Esp 2003;27:18-21
   PubMedGoogle Scholar
• Cheng L, Neumann RM, Weaver AL, et al. Grading and staging of bladder carcinoma in transurethral resection specimens: correlation with 105 matched cystectomy specimens. Am J Clin Pathol 2000;113:275-9
   PubMed Web of Science ®Google Scholar
• Satoh E, Miyao N, Tachiki H, et al. Prediction of muscle invasion of bladder cancer by cystoscopy. Eur Urol 2002;41:178-81
   PubMed Web of Science ®Google Scholar
• Soloway MS. Flexible urethrocystoscopy: alternative to rigid instruments for evaluation of lower urinary tract. Urology 1985;25:472-4
   PubMed Web of Science ®Google Scholar
• Stravodimos KG, Mitropoulos D, Salvari A, et al. Levobupivacaine intravesical injection for superficial bladder tumor resection: possible, effective and durable. Preliminary clinical data. Int Urol Nephrol 2007 [Epub ahead of print]
   Google Scholar
• Brausi MA, Verrini G, De Luca G, et al. The use of local anesthesia with N-DO injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis. Eur Urol 2007;52:1407-11
   PubMed Web of Science ®Google Scholar
• Jichlinski P, Lelsinger H-J. Fluorescence cystoscopy in the management of bladder cancer: a help of the urologist. Urol Int 2005;74:97-101
   PubMed Web of Science ®Google Scholar
• Spiess PE, Grossman HB. Fluorescence cystoscopy: is it ready for use in routine clinical practice? Curr Opin Urol 2006;16:372-6
   PubMed Web of Science ®Google Scholar
• Schmidbauer J, Marberger M. Recent developments in fluorescence cystoscopy: do novel agents bring a benefit? Curr Opin Urol 2007;17:347-51
   PubMed Web of Science ®Google Scholar
• Marti A, Jichlinski P, Lange N, et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced porphyrin IX distribution in human bladder cancer. J Urol 2003;170:428-32
   PubMed Web of Science ®Google Scholar
• Lange N, Jichlinski P, Zellweger M, et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexyl-ester-induced porphyrin IX: a pilot study. Br J Cancer 1999;80:185-93
   PubMed Web of Science ®Google Scholar
• Joudi FN, Konety BR. Fluorescence cystoscopy and bladder surveillance. Curr Opin Urol 2004;14:265-70
   PubMed Web of Science ®Google Scholar
• Van Der Meijden AP, Sylvester R, Oosterlinck W, et al. EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 2005;48:363-71
   PubMed Web of Science ®Google Scholar
• May F, Treiber U, Hartung R, et al. Significance of random bladder biopsies in superficial bladder cancer. Eur Urol 2003;44:47-50
   PubMed Web of Science ®Google Scholar
• Jichlinski P, Guillou L, Karlsen SJ, et al. Hexyl aminolevulinate fluorescence cystoscopy: a new diagnostic tool for the photodiagnosis of superficial bladder cancer-a multicenter study. J Urol 2003;170:226-9
   PubMed Web of Science ®Google Scholar
• Schmidbauer J, Witjes F, Schmeller N, et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004;171:135-8
   PubMed Web of Science ®Google Scholar
• Jocham D, Witzes F, Wagner S, et al. Improved detection and treatment of bladder cancer using hexaminolevunilate imaging: a prospective, phase III multicenter study. J Urol 2005;174:862-6
   PubMed Web of Science ®Google Scholar
• Hungerhuber E, Stepp H, Kriegmair M, et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 2007;69:260-4
   PubMed Web of Science ®Google Scholar
• Grossman HB, Gomella L, Fradet Y, et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficially papillary lesions in patients with bladder cancer. J Urol 2007;178:62-7
   PubMed Web of Science ®Google Scholar
• Fradet Y, Grossman HB, Gomella L, et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007;178:68-73
   PubMed Web of Science ®Google Scholar
• Burger M, Zaak D, Stief CG, et al. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Eur Urol 2007;52:142-7
   PubMed Web of Science ®Google Scholar
• Loidl W, Schmidbauer J, Susani M, et al. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance. Eur Urol 2005;47:323-6
   PubMed Web of Science ®Google Scholar
• Witjes JA, Moonen PM, Van Der Heijden AG. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy in bladder cancer: results of a prospective phase II study. Eur Urol 2005;47:319-22
   PubMed Web of Science ®Google Scholar
• Junker K, Kania K, Fiedler W, et al. Molecular genetic evaluation of fluorescence diagnosis in bladder cancer. Int J Oncol 2002;20:647-53
   PubMed Web of Science ®Google Scholar
• Wiener HG, Remkes GW, Mian C, et al. Can urine bound diagnostic test replace cystoscopy in the management of bladder cancer? J Urol 1998;159:1876-80
   PubMed Web of Science ®Google Scholar
• Soloway MS. Do we have a prostate specific antigen for bladder cancer? J Urol 1999;161:447-8
   PubMed Web of Science ®Google Scholar
• Lokeshwar VB, Soloway MS. Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol 2001;165:1067-77
   PubMed Web of Science ®Google Scholar
• Van Der Poel HG, Debruyne FM. Can biologic markers replace cystoscopy? An update. Curr Opin Urol 2001;11:503-9
   PubMed Web of Science ®Google Scholar
• Messing E. Markers of detection. Urol Oncol 2007;25:344-7
   PubMed Web of Science ®Google Scholar
• Yossepowitch O, Herr HW, Donat SM. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. J Urol 2007;177:1277-82
   PubMed Web of Science ®Google Scholar
• Hong YM, Loughlin KR. Economic impact of tumor markers in bladder cancer surveillance. Urology 2008;71:131-5
   PubMed Web of Science ®Google Scholar